Stock ABIO ARCA BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights ARCA biopharma, Inc.

Equities

ABIO

US00211Y5069

Market Closed - Nasdaq
Other stock markets
 21:00:00 15/05/2024 BST 		5-day change 1st Jan Change
3.72 USD +12.05% Intraday chart for ARCA biopharma, Inc. +10.71% +118.82%
04-25 ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-19 North American Morning Briefing : Stock Futures -2- DJ

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
North American Morning Briefing : Stock Futures -2-
DJ
Sector Update: Health Care Stocks Softer Late Afternoon
MT
Top Midday Gainers
MT
Sector Update: Health Care Stocks Rise Wednesday Afternoon
MT
Sector Update: Health Care
MT
ARCA biopharma, Oruka Therapeutics Announce All-Stock Merger; Shares Surge
MT
ARCA biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
ARCA biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
ARCA biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
ARCA biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Earnings Flash (ABIO) ARCA BIOPHARMA Reports Q3 Loss $-0.16
MT
ARCA biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Earnings Flash (ABIO) ARCA BIOPHARMA Posts Q2 Loss $-0.22
MT
ARCA biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Earnings Flash (ABIO) ARCA BIOPHARMA Reports Q1 Loss $-0.23
MT
ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
ARCA biopharma Says COVID-19 Treatment Study Fails to Meet Target; Shares Fall
MT
ARCA biopharma, Inc. Announces Results for ASPEN-COVID-19 Phase 2b Clinical Trial
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABIO Stock
  4. News ARCA biopharma, Inc.
  5. Highlights